Hyaluronic Acid Dermal Fillers (Saypha)

Volume restoration and wrinkle filling using Saypha hyaluronic-acid fillers — premium biocompatible products from Austrian manufacturer Croma — administered by MUDr. Irena Hejcmanová. Saypha Filler addresses fine-to-moderate wrinkles and lip definition; Saypha Volume is formulated for deeper structural support including cheek and jaw volume. Numbing cream is included. All injectable procedures are performed by the physician personally, never delegated to nursing staff.

Hyaluronic acid (HA) fillers work by introducing a cross-linked biocompatible gel into the dermis or subcutaneous tissue to physically restore volume, support sagging structures and smooth contour irregularities. Unlike botulinum toxin — which acts on muscle dynamics — fillers address static changes: hollowing, groove formation and volume loss that is visible at rest regardless of expression. Hyaluronic acid is a naturally occurring glycosaminoglycan found throughout the body's connective tissue and skin matrix; the cross-linked formulations used in medical aesthetics slow enzymatic degradation, extending the residence time in tissue to nine to twenty-four months depending on product density, placement depth and the patient's individual metabolism. At Derma-plus Tábor, MUDr. Irena Hejcmanová uses Saypha fillers manufactured by Croma Pharma — a CE-marked Austrian medical device company with a strong European aesthetic medicine track record. Saypha Filler (1 ml, 3,200 Kč) is a monophasic HA gel of intermediate viscosity suited to filling moderate wrinkles — nasolabial folds, marionette lines, perioral lines — and providing fine lip definition. Saypha Volume (1 ml, 3,200 Kč) is a biphasic, higher G-prime formulation designed for structural support in deeper tissue planes: cheek volume augmentation, jaw contouring and lifting of the midface. Both contain 0.3% lidocaine to reduce procedural discomfort. The consultation with MUDr. Hejcmanová before injection covers facial proportions, skin thickness and tissue quality, the distribution of volume loss and the patient's aesthetic goals. This assessment determines which Saypha product, how many syringes and which injection technique (linear threading, fanning, bolus) are most appropriate for the target areas. Topical numbing cream is applied as a first step; the lidocaine in the filler itself further reduces sensation during delivery. Fine needles or blunt-tipped cannulas are used depending on the target zone. Results are visible immediately, though mild swelling and occasional bruising in the first three to five days can temporarily obscure the final contour. A follow-up review at two to four weeks allows assessment and any minor adjustments. Duration varies by product, depth and metabolic activity — Saypha Filler in the nasolabial region typically lasts nine to twelve months; Saypha Volume in the cheeks twelve to eighteen months or longer. The treatment is reversible: hyaluronidase enzyme can dissolve HA filler if needed. Contraindications include active infection at the injection site, autoimmune disease affecting connective tissue and pregnancy.